Pharmacokinetics | European Cystic Fibrosis Society (ECFS)

Examining the potential for drug interactions with Trikafta®/Kaftrio® in people with cystic fibrosis

Evaluation of a novel compound, AZD5634, in healthy volunteers and patients with cystic fibrosis

Drug levels and dosing recommendations for antibiotics used to treat Mycobacterium avium complex in people with cystic fibrosis.

In Vivo demonstration of Pseudomonas aeruginosa biofilms as independent pharmacological microcompartments

Accumulation and persistence of Ivacaftor in airway epithelia with prolonged treatment

Ceftaroline Pharmacokinetics and Pharmacodynamics in Patients with Cystic Fibrosis

Optimizing beta-lactam pharmacodynamics against Pseudomonas aeruginosa in adult cystic fibrosis patients.